Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)

20250 citationsJournal Articlehybrid Open Access

Authors

EudraCT: 2016-005147-17; ClinicalTrials.gov: NCT03468335.

Published in: British Journal of Cancer

Volume 134, Issue 1, pp. 85-91

Field-Weighted Citation Impact: 0.00